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Background. The purpose of this study was to assess the post-exercise O2 uptake and heart rate response in patients with heart
failure (HF) in comparison to healthy individuals. Methods and Results. Exercise testing of all subjects was conducted according to
the RITE-protocol. The study subjects were classiﬁed according to their peak oxygen uptake (peak VO2)i nf o u rg r o u p s :h e a l t h y
individuals with a peak VO2 >22mL/kg/min (group 1, n: 50), and patients with HF and a peak VO2 of 18–22mL/kg/min, (group
2, n: 48), 14–18mL/kg/min (group 3, n: 57), and <14mL/kg/min (group 4, n: 31). Both peak VO2 and HR declined more slowly in
the patients with HF than in the normal subjects. Recovery of VO2 and HR followed monoexponential kinetics in the early post-
recovery phase. This enabled the determination of a time constant for both HR and VO2 (TCVO2 and TC HR). From group 1 to 4
therewasaprolongationofthetimeconstantforVO2 andHR:TCVO2 (group1:110±34,group2:197±43,group3:238±80,and
group 4: 278±50sec), and TC HR (group 1: 148±82, group 2: 290±65, group 3: 320±58, and group 4: 376±55sec). Conclusion.
T h er a t eo fd e c l i n eo fV O 2 and HR in the early post-exercise phase is inversely related to the peak VO2. The time constant for
oxygen uptake (TC VO2) and heart rate (TC HR) might prove a useful parameter for more precise monitoring and grading of HF.
1.Introduction
Oxygen uptake kinetics and heart rate response during
exercise have been extensively studied in both normal sub-
jects and patients with heart failure [1–3]. Anaerobic thresh-
old and maximal oxygen uptake are reliable parameters for
assessing the functional capacity of an individual and de-
termining the progression of heart failure, response to
medication, and overall prognosis [4–6]. Exercise and the
early postexercise phase can be considered as a continuum,
andsymptomssuchasdyspneaandfatigueappearingduring
exercise are prominent also in the ﬁrst post-exercise minutes.
Cole et al. [7]showedthatadelayeddecreaseintheheartrate
during the ﬁrst minute after graded exercise is a powerful
predictor of overall mortality, independent of changes in
heart rate during exercise. Similar results were published
by Tang et al. [8] in heart failure patients and by Lacasse
et al. [9] in patients with obstructive lung disease. De Groote
et al. [10] found that kinetics of oxygen consumption during
recoverywasdelayedinpatientswithdilatedcardiomyopathy
and that the ratio between total oxygen consumption during
exercise and recovery was an independent prognostic marker
in patients with moderate exercise intolerance. The purpose
ofthisstudywastocompareheartrateandoxygenconsump-
tion in the early recovery phase after maximal, symptom-
limited exercise in patients with diﬀerent functional stages
of heart failure and in healthy individuals.
2. Methods
2.1. Study Population. The study included 136 patients with
heart failure referred for symptom-limited cardiopulmonary
exercisetestingaswellas50age-matchedhealthyindividuals.
The diagnosis of heart failure was made on the basis of2 Cardiology Research and Practice
Table 1: Clinical characteristics of 136 patients who achieved peak exercise level.
Age (yr) 51 ± 13
Range 24–70
Men/women 89/61
Etiology of heart failure
CAD 92 (67%)
Idiopathic dilated cardiomyopathy 53 (39%)
Valvular disease 5( 4 % )
Left ventricular ejection fraction (%) 30 ± 12
NYHA functional class (FC)
II 48 (35%)
III 57 (42%)
IV 31 (23%)
Medication (%)
ACE inhibitors Beta-blockers Diuretics
FC II 75 30 89
FC III 88 28 97
FC IV 86 17 98
Data are expressed as mean value ± SD or number of patients, unless otherwise indicated.
history taking, clinical evaluation and estimation of systolic
pump function of the left ventricle (ejection fraction <40%
measured by echocardiography and/or left ventriculogra-
phy). Patients were excluded if they could not exercise maxi-
mally for noncardiac reasons such as severe pulmonary
disease, peripheral vascular occlusive disease and orthopedic
or neurological disease. Patients with a pacemaker were also
excluded. Patients’ medication was not withdrawn before the
test, and no patient was taking part in a regular exercise pro-
gram. The study conforms with the principles outlined in
the Declaration of Helsinki. The baseline demographic and
clinical characteristics are shown in Table 1.
2.2. Cardiopulmonary Exercise Testing. Exercise testing of all
patientswasconductedaccordingtotheRampingIncremen-
tal Treadmill Exercise (RITE) Protocol [11]. In this symp-
tom-limited treadmill exercise protocol initial elevation and
velocity are 4% and 1mph, respectively. After each minute of
exercise, elevation increases by 1% and velocity by 0.5mph.
Patientswereencouragedtoexerciseuntilsymptomswerein-
tolerable. Investigator-determined exercise end points were
nonsustained ventricular tachycardia (>5 beats), any sus-
tained arrhythmia, high-degree AV block, ST-segment
depression >3mm, systolic blood pressure >230mmHg, or
progressive decrease in blood pressure.
Exhaled gases were analyzed on a breath-by-breath basis
using a respiratory gas analyzer (MedGraphics Cardio O2,
CA, USA). Oxygen uptake (VO2), carbon dioxide output
(VCO2), tidal volume (VT), and breathing rate were mea-
sured.
2.3. Cardiopulmonary Parameters. From the above data,
minute ventilation (VE), respiratory exchange ratio
(VCO2/VO2), the O2 pulse (VO2/HR), and the ventilatory
equivalentsforO2 andCO2 (VE/VO2,VE/VCO2)werecalcu-
lated. Peak VO2 was determined as the highest VO2 achieved
during exercise.
The anaerobic threshold was measured with the V-slope
method [12]. Typical changes in ventilatory equivalents and
end-tidal gas concentrations (PET O2 and PET CO2)w e r e
examined to search for agreement in cases that were ques-
tionable with regard to the precise anaerobic threshold val-
ues. Predicted maximal VO2 was determined by using the re-
gression equations of Wasserman et al. [13]. Functional ca-
pacity (FC) was deﬁned as the percentage of the predicted
(for sex, age, and body weight) maximal VO2 reached. Post-
exercise heart rate and oxygen consumption kinetics were
described using a time constant (TC).
To quantify the time course of the VO2 decrease, we cal-
culated the natural logarithm of VO2 at 5 points: peak VO2
and VO2 at 30, 60, 90, and 120sec of the post-exercise
period. The linear regression of the natural logarithm over
time was expressed as y =− A · x + B,( A, B = constant).
The time constant was then obtained by −1/A and was
e x p r e s s e da sT CV O 2 (s) (Figure 1). In a similar manner, the
time constant for heart rate decrease TC HR was calculated.
The correlation constant r showed the level of correlation of
post-exercise VO2 or HR with a monoexponential curve.
The study subjects were classiﬁed according to their
peak VO2 into four groups: group 1 with a peak VO2 >
22mL/kg/min (n: 50), group 2 with 18–22mL/kg/min, (n:
48), group 3 with 14–18mL/kg/min (n: 57), and group IV
with <14mL/kg/min (n: 31), respectively.
2.4. Statistical Analysis. Continuous variables are expressed
as mean value ± standard deviation and are compared using
an unpaired t-test. A P value of <0.05 was required for
statistical signiﬁcance.Cardiology Research and Practice 3
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Figure 1: Example of calculation of the time constant (TC) value for the ﬁrst 2 postexercise minutes. TC expresses the time (in sec) after
which VO2 has declined 63% below the peak value.
3. Results
The four study groups were similar with respect to age and
sex distribution. A total of 136 patients and all 50 healthy
subjects exercised until the peak exercise level, deﬁned as
the exercise level at which the subject reached at least 80%
of predicted maximal heart rate and 50% of his or her
respiratoryreserve.Theclinicalcharacteristicsofthepatients
are shown in Table 1.
For TC VO2, the correlation coeﬃc i e n tw i t ham o n o e x -
ponential curve was above 0.97 (mean ± SD = 0.98 ± 0.01)
in the 50 normal controls and above 0.95 (0.97±0.02) in the
136 patients. Correlation coeﬃcient for TC HR was above
0.95 (0.98±0.02) in controls and above 0.95 (0.97±0.03) in
patients. We found no patient with a correlation coeﬃcient
of less than 0.90 for either TC VO2 or TC HR. High values
of the correlation coeﬃcient indicate that both VO2 and
HR declined monoexponentially in the ﬁrst 2 minutes of
recovery. After the ﬁrst 2 minutes, neither heart rate nor oxy-
gen consumption curves were monoexponential and for that
reason no comparison between the diﬀerent groups could be
made for this period of time.
Peak heart rate diﬀered signiﬁcantly between the four
groups and was lower in the groups with reduced functional
capacity (Table 2). The rate of decline of heart rate and oxy-
gen consumption was inversely related to the functional
capacity.Innormalsubjects,heartrateandoxygenconsump-
tion declined rapidly as this was expressed by a low TC
(TC-VO2 110 ± 34, TC-HR 148 ± 82sec), and 90% of them
had reached at least 1/2 of the base-line heart rate and
oxygen consumption by 120sec in the recovery period. In
the patients with heart failure, heart rate and oxygen con-
sumption declined more slowly than in normal subjects. The
rate of decline was slower with a reduced functional capacity.
By 120sec in the recovery period, 90% of the patients in
group 2 had reached at least 1/2 of the base-line heart rate
andoxygenconsumption,whilethiswasthecaseinonly50%
and 20% in groups 3 and 4, respectively. Patients on beta-
blockers tended to have a lower peak heart rate than patients
without beta-blocking medication: peak HR in bpm, FC 70–
90: 128±10 versus134±12,P: 0.08,FC50–70: 118±9v e r s u s
126 ± 12, P: 0.07, and FC <50: 106 ± 9 versus 111 ± 12,
P: 0.09. There was no diﬀerence in the time constants for
heart rate and oxygen consumption: TC for HR in sec: FC
70–90: 285 ± 66 versus 291 ± 64, P: 0.56, FC 50–70: 323 ±
62 versus 318±50, P: 0.33, FC <50: 374±58 versus 377±52,
P:0.23.TCforVO2 insec:FC70–90:199±45versus198±43,
P: 0.25, FC 50–70: 240 ± 80 versus 237 ± 80, P: 0.43, FC
<50: 280 ±52 versus 277 ± 50, P: 0.44.
4. Discussion
Patients with clinically manifest heart failure have a de-
creased exercise capacity. During exercise, symptoms such as
dyspnea and fatigue appear in relatively early stages and ac-
count for termination of exercise before maximum levels are
reached. The severity of the impairment has been quantiﬁed
by several types of exercise testing. Among the parameters,
anaerobic threshold, peak VO2, and the ratio of the increase
in VO2 to the increase in work rate (ΔVO2/ΔWR), which
are obtained from respiratory gas exchange analysis, have
been employed by many investigators because of their good
sensitivity and noninvasive mode of determination.
In this study, we found that patients with heart failure
compared to normal individuals show a diﬀerent response of
heart rate and oxygen uptake not only during exercise but
also in the ﬁrst minutes of recovery. For the ﬁrst 2 minutes
after the cessation of exercise, the VO2 time relationship de-
clined monoexponentially. During this early period of recov-
ery oxygen uptake declines rapidly and the rate of decline
seems to be related to the resynthesis of phosphocreatine and
reloading of myoglobin and hemoglobin with oxygen [14].
Thus, one of the reasons for the slower decline of recovery,
oxygen uptake in patients with heart failure seems to be the
impaired ability of the circulatory system to deliver rapidly
the amount of oxygen needed for replenishment of myoglo-
bin in the peripheral muscles. This is supported by the study
of Tanabe et al. [15] in which slower recovery kinetics of VO24 Cardiology Research and Practice
Table 2: Results of exercise testing.
(%) n AT (mL/min/kg) Peak VO2 (mL/min/kg) ΔVO2/ΔWRs (mL/min/W)
FC >90 50 18.4 ± 63 1 ±7 11.6 ± 0.9
FC 70–90 48 14 ± 42 2 ± 49 . 6 ± 0.8
FC 50–70 57 8 ± 31 7 ± 48 . 5 ±1.0
FC <50 31 6 ± 21 0 ± 25 . 2 ± 1.3
(%) VE/VCO2 Peak ex. Peak HR (bpm) TC (VO2) (sec) TC (HR) (sec)
FC >90 27 ±2.8 154 ±22 110 ±34 148 ±82
FC 70–90 31 ±3.5 132 ±11 197 ±43
∗ 290 ±65
∗
FC 50–70 37 ±5.6 123 ±12 238 ±80
∗ 320 ±58
∗
FC <50 45 ±7.2 110 ±10 278 ±50
∗ 376 ±55
∗
n : number of cases, AT: anaerobic threshold, peak VO2:o x y g e nu p t a k ea tp e a ke x e r c i s e ,ΔVO2/ΔWR: ratio of the increase in oxygen uptake to the increase
in work rate, VE/VCO2 peak Ex.: respiratory equivalent for carbon dioxide at peak exercise, peak HR: heart rate at peak exercise, TC (VO2)a n dT C( H R ) :
time constant for the postexercise oxygen uptake and heart rate, respectively. P<0.05 for all parameters of each group compared to the previous group (i.e.,
FC <50% versus FC 50–70%, FC 50–70% versus FC 70–90%, and FC 70–90% versus FC >90%). Values are expressed as means ± SD. ∗P<0.05 for the
comparison with the previous groups.
and VCO2 correlated very well with the impairment of cir-
culatory response to exercise and delayed recovery of cardiac
output. The fact that peak VO2 and indexes of recovery did
notcorrelatewithejectionfractionofleftventricleatrestwas
also shown by Tang et al. [8] and emphasizes that a dynamic
interplay of cardiac muscle contractility, heart rate, periph-
eral vascular resistance, and venous ﬁlling takes place during
exercise and the recovery phase, rendering left ventricular
ejection fraction at rest a poor predictor of exercise capacity.
Another factor that possibly contributes to the slower recov-
ery kinetics of VO2 in heart failure is the impaired oxygen
transport across the capillary-alveolar membrane in the
lungs. It is known that signiﬁcant alterations of pulmonar-
y function occur in heart failure patients [16]. These include
increased pulmonary restriction, ventilation-perfusion mis-
match with an increase of the physiological dead space, and
increased respiratory eﬀort for a given workload compar-
ed to a healthy population. Such alterations are believed to
result from ﬂuid accumulation in the interstitial space sec-
ondary to increased pulmonary capillary pressure and are
more pronounced during exercise. Elevation of VE/VCO2,
which reﬂects an increase in ventilatory dead space, was
found to correlate with a decreasing functional capacity in
this and other studies [17, 18]. Because VO2 is related to
oxygen extraction as well as cardiorespiratory function, the
prolongation of VO2 decline during recovery may result
also from the altered utilization of oxygen in muscles and
other organs. It is known that patients with heart failure
have reduced oxygen reserves, impaired oxygen transport,
and muscle metabolism as well as muscle atrophy [19–21].
Cohen-Solal et al. [22] found a good correlation between the
recovery half-time of oxygen consumption and the recovery
half-time of the Pi/PCr ratio of the anterior leg muscle in pa-
tients with heart failure.
In this study, heart rate at rest and at maximal exercise
was signiﬁcantly lower in healthy subjects than in patients
with heart failure. The diﬀerences in resting heart rate may
well be attributed to the decrease of vagal tone in combina-
tion with an increased adrenergic tone, which occur as some
of the earlier neural compensatory mechanisms in the course
of heart failure. At comparable exercise stages and in the ab-
sence of chronotropic incompetence, heart rate in heart fail-
urepatientstendstobehigherthaninhealthysubjects.Heart
rate “overshoot” is a compensatory mechanism for the im-
paired augmentation of stroke volume of the failing myocar-
dium during increasing exercise. Patients with heart failure
reach their maximal exercise capacity in earlier exercise
stages, than age- and sex-matched healthy subjects. This is
one of the reasons to explain the lower maximal heart rate in
heart failure patients observed in this and other [8] studies.
Patientswithβ-blockingmedicationtendtohavelowermax-
imalheartratesthanpatientswithout.However,inthisstudy
the diﬀerence did not reach statistical signiﬁcance, probably
because of the relatively low dose of ß-blockers used (about
1/4 to 1/8 of the currently maximal recommended dose).
In this study, recovery of heart rate in patients with mild
heart failure (functional capacity 70–90%) lasted approxi-
mately twice as long as in healthy individuals (TC HR: 290 ±
65 versus 148 ± 82sec). Further prolongation of heart-
rate recovery kinetics was observed with decreasing func-
tional capacity. Imai et al. [23] examined the physiologic
characteristics of heart rate recovery after exercise in healthy
adults, athletes, and patients with heart failure. They demon-
strated that in all three groups, vagal reactivation was the
principal determinant of the decrease of heart rate during
early recovery. This mechanism is independent of age and
intensity of exercise. In heart failure-impaired vagal reactiva-
tion causes a slower decrease of heart rate during recovery.
Considering the relationship between autonomic tone
imbalance and cardiac mortality [24, 25], it is not surprising
thatadelayeddecreaseofheartrateduringrecoveryfromex-
ercise is a powerful predictor of mortality [7].
The role of sympathetic nervous system in heart failure is
pivotal. In their interesting work, Lambert et al. [26] exam-
inedthecardiacandwholebodysympatheticnervoussystem
activity in patients with severe heart failure and have been
able to demonstrate an association between the increased
release of central nervous system monoamine neurotrans-
mitters and the sympathoexcitation that is variably present
in treated heart failure patients. In their work, Kaye et al.Cardiology Research and Practice 5
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Figure 2: Schematic presentation of the mean VO2 recovery curves for the four groups.
[27] quantiﬁed whole-body and cardiac sympathetic activity
in patients with heart failure and correlated them to clinical
outcome, thus providing evidence for the deleterious eﬀect
of sympathetic activation in heart failure. Finally, Hasking
et al. [28] showed that in patients with heart failure continu-
ously increased sympathetic tone can induce an end-organ
refractoriness to adrenergic stimulation, as expressed by a
blunted response to exercise. All these studies underpin the
use of beta-blockers in heart failure [29].
Inourstudy,patientswithheartfailurethatwereonbeta-
blockershadtendentiallylowerpeakheartratesthanpatients
without beta blocking medication. Beta-blockade did not
inﬂuence the time constants for heart rate and VO2 recov-
ery among patients of the same functional class (Figure 2).
This ﬁnding is in accordance with other studies that have
shown also a negligible eﬀect of beta-blockade on heart rate
recovery after exercise (Figure 3)[ 30, 31]. This supports the
hypothesis that although heart failure patients have a high-
resting sympathetic tone as reﬂected by the elevated resting
heartrates,decreaseofheartrateaftermaximalexerciseisin-
ﬂuenced primarily by the activation of vagal tone, while pro-
longed sympathetic activation seems to play a minor role at
least during early recovery period.
5. Limitations
We assessed the kinetics of oxygen uptake and heart rate dur-
ing early recovery after symptom-limited maximal exercise
by the use of a ramping incremental protocol. How TC VO2
and TC HR change during other types of exercise, especially
in submaximal exercise or by using a bicycle ergometer, re-
mains to be determined.
The number of patients with heart failure who were un-
der β-blocking medication was relatively small, and the dose6 Cardiology Research and Practice
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Figure 3: Examples of VO2 and HR recovery after exercise with the corresponding time constant in a normal individual (a), (b) and in a
patient with heart failure (c), (d).
used was lower than currently recommended. For that rea-
son, the eﬀect of ß-blockade on VO2 kinetics and heart rate
response cannot be evaluated.
6. Conclusions
Reductionoffunctionalcapacityisassociatedwithprolonga-
tion of the early recovery of oxygen consumption and heart
rate after maximal exercise. The time constants TC VO2 and
TC HR characterize the monoexponential decline of oxygen
consumption and heart rate in the ﬁrst 2 minutes of recov-
ery and might be useful parameters in the diagnosis and
management of heart failure.
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